Press/Media
- 75 - 100 out of 479 results
Search results
-
Two-bagger Rezolute (NV) (RZLT: $4.68) lifts 3.5%; +16c [3.5%]
29/07/24
1 item of Media coverage
Press/Media
-
University of Ulsan College of Medicine Researcher Publishes New Study Findings on Gastric Cancer (Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival ...)
Kim, Y., Lee, J.-S. & Kim, W.-S.
25/07/24
1 item of Media coverage
Press/Media
-
Weekly: Rezolute (NV) (RZLT: $4.52) drops 3.8% on firm volume; -18c [3.8%]
22/07/24
1 item of Media coverage
Press/Media
-
Research Findings from Sungkyunkwan University School of Medicine Update Understanding of COVID-19 (Risk Factors for Impaired Cellular or Humoral Immunity after Three Doses of SARS-CoV-2 Vaccine in Healthy and Immunocompromised Individuals)
Kim, Y., Kim, J.-H. & Lee, W. H.
18/07/24
1 item of Media coverage
Press/Media
-
Chosun University Researchers Describe New Findings in COVID-19 (SARS-CoV-2 antigenemia and RNAemia in association with disease severity in patients with COVID-19)
17/07/24
1 item of Media coverage
Press/Media
-
Reports Outline COVID-19 Study Results from Chung-Ang University Hospital (ECMO is associated with decreased hospital mortality in COVID-19 ARDS)
16/07/24
1 item of Media coverage
Press/Media
-
Two-bagger Rezolute (NV) (RZLT: $4.70) surges 14%; +57c [13.8%] Vol Index 1.3 [1 is avg]
15/07/24
1 item of Media coverage
Press/Media
-
Rezolute (NV) soars 331% in 2024, outperforming 99% of its global peers
12/07/24
1 item of Media coverage
Press/Media
-
Hanyang University Medical Center Reports Findings in Thyroid Cancer (Prognosis of Poorly Differentiated Thyroid Carcinoma: A Systematic Review and Meta-Analysis)
8/07/24
1 item of Media coverage
Press/Media
-
Weekly: Rezolute (NV) (RZLT: $4.13) lifts 3.0% - outperforming 99% of stocks; +12c [3.0%]
8/07/24
1 item of Media coverage
Press/Media